Clinical Trial Update: Interleukin-2 Following Bone Marrow Transplantation in Treating Patients With Hematologic Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating Interleukin-2 after bone marrow transplantation for hematologic cancers has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Lymphoma
• Multiple Myeloma
• Plasma Cell Neoplasm

Drugs mentioned

• Interleukin-2 (interleukin-2)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Leukemia, Lymphoma | Phase 1 | Status: COMPLETED